AI Networking Cookbook: Practical recipes for AI-assisted network automation and development
We have 3 of 22 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Beyond conventional therapies: the evolution of targeted agents and immunotherapies in triple-negative breast cancer
Key approaches targeting DNA repair deficiency, immune regulation, oncogenic signaling pathways, and antigen-directed therapies are highlighted, and their clinical development and application are discussed.
Drugging ERK1/2 in Cancer: A Glimpse of Small-Molecule Inhibitors.
The historical milestones in ERK1/2 research are outlined, from their discovery and structural characterization to their identification as oncogenic drivers and therapeutic targets, and the potential of ERK1/2-targeted therapies in precision oncology is highlighted.